Clinical Trial: A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Pilot Study to Compare Tretinoin Gel, 0.05% to Tretinoin Gel Vehicle When Dosed Once or Twice Daily in Female Subjects With Classical Rosacea

Brief Summary: To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.

Detailed Summary:
Sponsor: Coria Laboratories, Ltd.

Current Primary Outcome: Improvement in signs and symptoms of rosacea [ Time Frame: 16 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Changes in various skin parameters [ Time Frame: 16 weeks ]

Original Secondary Outcome: Same as current

Information By: Coria Laboratories, Ltd.

Dates:
Date Received: February 12, 2008
Date Started: February 2008
Date Completion:
Last Updated: December 17, 2008
Last Verified: December 2008